Much-hyped Moderna barrels into the clinic with 6 human trials planned for ’16

Damian Garde

Therapeutics, a superlatively well-funded private biotech, has made the leap from preclinical bluster to first-in- , testing out its inaugural candidate and planning to move 5 more the this year.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS